Hearing loss (HL) is the most common birth defect and the most prevalent sensorineural condition worldwide. It is associated with more than 1,000 mutations in at least 90 genes. Mutations of the gap junction beta-2 protein (GJB2) gene located in the nonsyndromic hearing loss and deafness (DFNB1) locus (chromosome 13q11-12) are the main causes of autosomal recessive nonsyndromic hearing loss worldwide, but important differences exist between various populations. In the present article, two common mutations of the GJB2 gene are compared for ethnic-specific allele frequency, their function, and their contribution to genetic HL in different populations. The results indicated that mutations of the GJB2 gene could have arisen during human migration. Updates on the spectrum of mutations clearly show that frequent mutations in the GJB2 gene are consistent with the founder mutation hypothesis.
HEARING LOSS
Hearing loss (HL) is a common sensorineural disorder with an incidence of one in 500-1,000 children (Azadegan-Dehkordi et al., 2018; Montazer Zohour et al., 2012; Yazdanpanahi et al., 2013) . At least half of HL cases can be attributed to genetic factors and more than two thirds of these individuals are classified as having autosomal recessive nonsyndromic hearing loss (ARNSHL) (Koohiyan et al., 2018; Yazdanpanahi et al., 2013; Yazdanpanahi et al., 2015) . This condition can occur in about 10% of the general population and its prevalence increases with age (Bolz, 2016) . The disorder is highly heterogeneous; every population has a unique HL etiologic profile depending on the geographic, ethnic, medical, and social factors (Mikstiene et al., 2016) .
The degree of HL is classified according to the PTA as mild (21-45 dB), moderate (46-60 dB), moderately severe (61-75 dB), severe (76-97 dB), and profound (>97 dB) (http://hereditaryhearingloss.org).
GENETIC HEARING LOSS
Genetic HL can be autosomal recessive (Kelsell et al., 1997) , autosomal dominant, X-linked recessive (Morton, 1991) , and mitochondrial (Prezant et al., 1993; Usami et al., 1997) . Research into the genetics of deafness has shown that mutations in the gap junction beta 2 (GJB2) gene (GenBank M86849, OMIM: *121011) reside at the chromosomal location 13q11 and cause nonsyndromic recessive HL (Guilford et al., 1994; Kelsell et al., 1997) . At least 42 genetic loci are associated with syndromic forms and over 163 genetic loci are associated with nonsyndromic HL (https://hereditaryhearingloss.org).
The prevalence of GJB2 mutations varies among ethnic groups. Some variants occur preferentially, but not exclusively, in distinct ethnic groups (Hellstrom, 2018) . To date, more than 150 variants, including polymorphisms, mutations, and unclassified variants, have been reported for GJB2 (https://davinci.crg.es/deafness).
ROLE OF GJB2 GENE IN HEARING LOSS
GJB2 should be considered in childhood-onset or congenital ARNSHL (MIM#121011), because expression of GJB2 transmembrane proteins has been documented in cell and tissue types that play key roles in tissue physiology. These proteins have several transmembranes (extracellular, cytoplasmic domains, C-terminus, N-terminus domains). The cytoplasmic domain and C-terminus are quite variable in length and sequence (Haefliger et al., 1992) , whereas other domains are highly conserved among connexins. In the cochlea, GJB2 have been proposed for the maintenance of normal potassium (K + ) homeostasis by ferrying K + away from the hair cells during auditory transduction (Selli et al., 2016) . Recently, studies have shown that channels formed by connexins are responsible for intracellular transduction of the inositol triphosphate (IP3), cAMP, atomic glutathione, glutamate (Harris, 2001) , ADP, ATP, and even siRNAs (Harris et al., 2009 ) is also essential for sound perception (Beltramello, Piazza, Bukauskas, Pozzan, & Mammano, 2005) , electrical conduction in the myocardium (Langlois et al., 2007) , and electrical signaling between neurons (Flores et al., 2012; Mathias, White, & Gong, 2010) . The presence of connexin in vertebrates and urochordata can confirm its specificity in these creatures (Cruciani, & Mikalsen, 2006; Isakson, and Thompson, 2014; Sasakura et al., 2003; Volff, Lehrach, Reinhardt, & Chourrout, 2004 ).
GJB2 MUTATIONS
There have been over 92 recessive GJB2 mutations, nine dominant mutations, 10 unknown mutations described (https://davinci.crg.es/deafness/index.php), all responsible for ARNSHL; however, only nine dominant GJB2 mutations are responsible for syndromic deafness (https://davinci.crg.es/ deafness/index.php). The spectrum and prevalence of GJB2 mutations vary among different populations.
Mutation c.35delG (chr13:20763686: C>-) in the GJB2 gene has been reported to be the most important variant in the gene that causes HL among Caucasians (Gasparini et al., 2000; . This mutation is homozygous and as a compound heterozygous state is responsible for 10% and 20% of all childhood hereditary HL in American Caucasians originating from northern and southern Europeans, respectively (Antoniadi et al., 2000; Duman, and Tekin, 2012; Gabriel et al., 2001; Janecke et al., 2002; Lopponen et al., 2003; Minarik, Ferakova, Ficek, Polakova, and Kadasi, 2005; Roux et al., 2004; Santos et al., 2005; Seeman et al., 2004) . The c.35delG mutation is the most common variant found in Mediterranean families (Duman, & Tekin, 2012) and different European populations (Batissoco et al., 2009; Dalamon et al., 2016; Gasparini et al., 2000; Kelley et al., 1998) . It also has been found in a heterozygous state in Muslim Israeli-Arab kindred from Italy, Spain, and Lebanon (Gasparini et al., 2000; Lucotte, 2007; Sobe et al., 2000) .
The carrier frequency of c.35delG mutation is high in Europe and among Americans of European ancestry (Gasparini et al., 2000; Kelley et al., 1998) . However, the high frequency of c.35delG mutation in Caucasian populations is possibly the result of a founder effect rather than a mutational hot spot (Banjara, Mungutwar, Swarnkar, & Patra, 2016; Mustapha et al., 2001; Zoidl, & Dermietzel, 2010) . The frequency of the c.35delG mutation differs in the Iranian population, with a higher slope of mutation frequency from south to north and east to west (Bonyadi, Fotouhi, & Esmaeili, 2014; Chaleshtori et al., 2007; Galehdari, Foroughmand, Soorki, and Mohammadian, 2009; Najmabadi et al., 2002; Tabatabaiefar et al., 2011 ) and a frequency that is similar to that reported in neighboring Turkey and Pakistan.
In the current survey, GJB2 gene-related HL was slightly in evidence in nonsyndromic HL individuals in the Iranian population compared to others (Han et al., 2008; Kelley et al., 1998; Toth, Kupka, Blin, Pfister, & Sziklai, 2002) . GJB2 mutations make the phenotype highly variable. It appears that environmental factors, modifying genes, and other connexin genes (Mohamed et al., 2010; Snoeckx, Hassan, Kamal, Van Den Bogaert, & Van Camp, 2005) can play a role in HL and its phenotype. Although most GJB2 mutations are focused in the coding region of exon 2, several mutations have been detected in the noncoding region of the gene (Al-Qahtani et al., 2010; Denoyelle et al., 1999; Galehdari et al., 2009; Godbole et al., 2010; Green et al., 1999; Hamelmann et al., 2001; Janecke et al., 2002; Liu et al., 2002; Mani et al., 2009; Marlin et al., 2005; Matos et al., 2007; Matos et al., 2011; Najmabadi, and Kahrizi, 2014; Yuan et al., 2010) . After examining patients who had a recessive mutation in the coding region, a number of pathogen mutations in the GJB2 noncoding region have been identified and were responsible for HL. Reconstruction of the structure of the GJB2 surrounding genomic regions indicates that the founder has branched out worldwide in the past two or three centuries. These findings have major implications for the approach to HL diagnosis and prevention policies worldwide. The c.-23+1G>A mutation is located in the noncoding exon 1 regions, which affects splicing of the GJB2 transcript (Angeli, 2008) . The c.-23+1G>A mutation was first identified by Denoyelle et al. (Denoyelle et al., 1999) , then the nontranscription of the gene (Seeman, & Sakmaryova, 2006; Shahin et al., 2002; Toth et al., 2002) , heterozygosity (Najmabadi, & Kahrizi, 2014; Sirmaci, Akcayoz-Duman, & Tekin, 2006) , compound heterozygosity, and homozygosity were proven in different patients (Janecke et al., 2002; Medica, Rudolf, Balaban, and Peterlin, 2005; Najmabadi et al., 2005; Prasad, Cucci, Green, and Smith, 2000; Yuan et al., 2010) . Signs of a human migration route have emerged (Y Chromosome Consortium, 2002) and there is no doubt that all of these gene mutations migrated along this route.
c.35delG MUTATION
The c.35delG mutation of the GJB2 gene is one of the most common causes of HL worldwide (75%). Studies show a high incidence of the c.35delG mutation in the Europe, Middle East, North America, and Africa. It appears that the Italy is the founder of this mutation (Amorini et al., 2015) . It is also abundant in eastern, southern, and central Asian regions (Tables  1 and 2 ). It has not been found in South Asian populations; therefore, we speculate that it was transferred to Africa and South America from North America, the Middle East, and Europe.
The frequency of this mutation in Iran decreases as one travels from north to south and west to east. It appears to have originated in northern Iran and increased with the expansion of immigration to other areas (Table 3 ). The high frequency of c.35delG in Caucasian populations possibly is the result of a founder effect rather than a mutational hot spot (Banjara et al., 2016; Mustapha et al., 2001; Zoidl, & Dermietzel, 2010) . This suggests that the c.35delG mutation transferred from an ancient ancestor. However, if it occurred in a common ancestor of modern humans, it would be observed in all populations; however, it is absent in South Asian and East Asian populations.
This suggests that the mutation occurred in an ancestor of the modern European, North American population, or Middle East Asian (Van Laer et al., 2001 ). It appears that the c.35delG mutation occurred about 100 centuries ago and was spread by migrants to other regions, from where it spread throughout Europe, North America, and Middle East Asia. It has been reported that the origin of the c.35delG mutation is central Asia and was transferred approximately 11,800 years ago (Dzhemileva et al., 2011) . Other study determined that the many GJB2 gene mutations, including c.35delG, were transferred through Iran to Europe by migration and to America by emigration (Najmabadi et al., 2005) . Because the c.-23+1G>A (chr13:20766921:C>T) mutation is in the noncoding region, it has been considered in fewer global studies; however, studies have also examined noncoding regions in addition to the coding area. The c.−23+1G>A mutation is a pathogenic mutation caused HL autosomal recessive that is located in the noncoding exon 1 region (https://deafnessvariationdatabase.org/letter/g), which affects splicing of the GJB2 transcript (Angeli, 2008) . This mutation has been reported at different frequencies among different populations and is especially frequent in the Mongolian, Yakut, Czech, Hungarian, and Turkish HL populations (Barashkov et al., 2016; Teryutin, Barashkov, Kunel'skaya, Pshennikova, and Solov'ev, 2016; Yuan et al., 2010 ). It appears that the mutation in East Asia and North and South America is not abundant and has the highest frequency in South Asia and parts of the Middle East. It is possible that these areas are the founder region from which it may have spread to other regions. This mutation decreased from north to south and west to east until it approaches zero in the southern regions. It is possible to say that northern Iran is the origin of this mutation and it expanded to other regions of Iran (Table 1) . Various studies have shown that this mutation is the second most common mutation after c.35delG mutation in Europe (Seeman, & Sakmaryova, 2006) and Iran (Zeinali et al., 2015) .
T A B L E 3 Spectrum allele frequency of two mutations of GJB2 in Iran

CONCLUSION
The difference in the distribution of mutations to various regions of the world indicates that they occurred from the ancestors of each ancestral generation and in immigrant populations at various time periods. Studies have found that c.35delG mutation first originated in the United States and the source of the c.−23+1G>A mutation are South Asia and areas of the Middle East. These results are relevant to further research on the genetic and molecular bases and the development of a national diagnostic tool in newborn hearing screening programs in Iran and elsewhere.
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